The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats

被引:9
作者
Darvesh, AS [1 ]
Gudelsky, GA [1 ]
机构
[1] Univ Cincinnati, Coll Pharm, Cincinnati, OH 45267 USA
关键词
glycogenolysis; hyperthermia; neurotoxicity; MDMA;
D O I
10.1016/j.ntt.2004.03.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although the exact mechanisms involved in the serotonergic neurotoxicity produced by substituted amphetamines are not completely known, evidence suggests that oxidative and/or bioenergetic stress may contribute in the mechanism of neurotoxicity of 3,4-methylenedioxymethamphetamine (NDMA). It has been postulated that MDMA-induced hyperthermia also contributes to the MDMA-induced neurotoxicity. N4DN4A produces brain glycogenolysis, and MDMA-induced hyperthermia appears to mediate this effect. The relationship of MDMA-induced hyperthermia and glycogenolysis in the serotonergic neurotoxicity of MDMA was investigated in the present study. The administration of MDMA (20 mg/kg sc) at an ambient temperature of 24 degreesC produced hyperthermia and brain glycogenolysis in Postnatal Day (PND)21 and PND70 rats; however, long-term reductions in serotonin (5-HT) concentrations in the striatum were detected only in the PND70 rats. Treatment of PND21 and PND70 rats with MDMA at 17 degreesC resulted in neither hyperthermia nor glycogenolysis; nevertheless, long-term reductions in 5-HT concentrations were still evident in the PND70 rats treated with MDNIA. These results support the conclusion that hyperthermia, as well as glycogenolysis, are neither necessary nor sufficient in the serotonergic neurotoxicity of MDNIA. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:571 / 577
页数:7
相关论文
共 59 条
[1]  
Aguirre N, 1998, J PHARMACOL EXP THER, V286, P1159
[2]  
BATTAGLIA G, 1987, J PHARMACOL EXP THER, V242, P911
[3]   EFFECTS OF A COLD ENVIRONMENT OR AGE ON METHAMPHETAMINE-INDUCED DOPAMINE RELEASE IN THE CAUDATE PUTAMEN OF FEMALE RATS [J].
BOWYER, JF ;
GOUGH, B ;
SLIKKER, W ;
LIPE, GW ;
NEWPORT, GD ;
HOLSON, RR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 44 (01) :87-98
[4]  
BOWYER JF, 1994, J PHARMACOL EXP THER, V268, P1571
[5]  
BOWYER JF, 1992, J PHARMACOL EXP THER, V260, P817
[6]  
BROENING HW, 1994, J PHARMACOL EXP THER, V271, P285
[7]  
BROENING HW, 1995, J PHARMACOL EXP THER, V275, P325
[8]   Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration [J].
Burrows, KB ;
Gudelsky, G ;
Yamamoto, BK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 398 (01) :11-18
[9]   RAPID ATP LOSS CAUSED BY METHAMPHETAMINE IN THE MOUSE STRIATUM - RELATIONSHIP BETWEEN ENERGY IMPAIRMENT AND DOPAMINERGIC NEUROTOXICITY [J].
CHAN, P ;
DIMONTE, DA ;
LUO, JJ ;
DELANNEY, LE ;
IRWIN, I ;
LANGSTON, JW .
JOURNAL OF NEUROCHEMISTRY, 1994, 62 (06) :2484-2487
[10]   THE SPIN TRAP REAGENT ALPHA-PHENYL-N-TERT-BUTYL NITRONE PREVENTS ECSTASY-INDUCED NEURODEGENERATION OF 5-HYDROXYTRYPTAMINE NEURONS [J].
COLADO, MI ;
GREEN, AR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 280 (03) :343-346